Resources with keywords: Creutzfeldt-Jakob disease (CJD)
Lab testing, case definition
Infection control measures and example of patient management ( appropriate confinement, containment, safe handling, disinfection, and disposal of contaminated materials and tissues generated during the course of hospitalization)
Infection control measures and Recommendations for disinfection and sterilization of prion-contaminated medical devices
Mead, Simon et al.
The Lancet Neurology, Volume 20, Issue 12, 981
The UK’s Advisory Committee for Dangerous Pathogens convened a subgroup to revise guidance for safe working with prions and to consider whether any measures were needed for work with proteopathic seeds, involving experts from research laboratories for prion and other neurodegenerative diseases, infectious disease specialists, pathologists, veterinarians, and health and safety experts.
Flow chart to manage samples from human or animal source
This guidance produced by the ACDP TSE risk management subgroup aims to help minimise the risk of transmission of Creutzfeldt-Jakob disease (CJD) and variant Creutzfeldt-Jakob disease (vCJD) in healthcare and other work settings.
